BioTech News Headlines - Yahoo! News

http://news.yahoo.com/biotech/ Get the latest Biotech news headlines from Yahoo! News. Find breaking Biotech news, including analysis and opinion on top Biotech stories, photos and more.en-USCopyright (c) 2013 Yahoo! Inc. All rights reservedThu, 01 Aug 2013 15:45:37 -04005http://news.yahoo.com/biotech/ http://l.yimg.com/a/i/us/nws/th/main_142c.gifShares of Affymetrix Inc. climbed Thursday, a day after the genetic testing instrument maker turned in a second-quarter performance that topped Wall Street expectations. THE SPARK: The Santa Clara, Calif., ...http://news.yahoo.com/affymetrix-shares-climb-2q-tops-194537613.htmlThu, 01 Aug 2013 15:45:37 -0400Associated Pressaffymetrix-shares-climb-2q-tops-194537613<p><a href="http://news.yahoo.com/top-french-court-backs-stem-cell-research-173058916.html"><img src="http://l1.yimg.com/bt/api/res/1.2/2X9ACReIjdgPrbygDFhxZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-08-01T173058Z_1_CBRE9701CNQ00_RTROPTP_2_FRANCE.JPG" width="130" height="86" alt="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" align="left" title="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" border="0" /></a>PARIS (Reuters) - France&#039;s top court approved a law on Thursday making it easier to conduct research on human embryos and stem cells as long as strict rules are followed to prevent cloning. Predominantly Roman Catholic France has until now had tough curbs on embryonic stem cell research under a 2011 law that only allows it with the explicit approval from the national biomedicine agency. ...</p><br clear="all"/>http://news.yahoo.com/top-french-court-backs-stem-cell-research-173058916.htmlThu, 01 Aug 2013 13:30:58 -0400Reuterstop-french-court-backs-stem-cell-research-173058916<p><a href="http://news.yahoo.com/top-french-court-backs-stem-cell-research-173058916.html"><img src="http://l1.yimg.com/bt/api/res/1.2/2X9ACReIjdgPrbygDFhxZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-08-01T173058Z_1_CBRE9701CNQ00_RTROPTP_2_FRANCE.JPG" width="130" height="86" alt="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" align="left" title="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" border="0" /></a>PARIS (Reuters) - France&#039;s top court approved a law on Thursday making it easier to conduct research on human embryos and stem cells as long as strict rules are followed to prevent cloning. Predominantly Roman Catholic France has until now had tough curbs on embryonic stem cell research under a 2011 law that only allows it with the explicit approval from the national biomedicine agency. ...</p><br clear="all"/>Genetic testing instrument maker Affymetrix Inc. said Wednesday it took a loss in the second quarter, but its shares advanced in aftermarket trading. Affymetrix said its revenue rose 20 percent, thanks ...http://news.yahoo.com/affymetrix-takes-2q-loss-shares-213120760.htmlWed, 31 Jul 2013 17:31:20 -0400Associated Pressaffymetrix-takes-2q-loss-shares-213120760A global agriculture biotechnology company is expanding its North Carolina operations with plans to add 150 new jobs within about five years. Syngenta Biotechnology Inc. said Tuesday it will expand its ...http://news.yahoo.com/crop-biotech-company-expand-150-173241540.htmlTue, 30 Jul 2013 13:32:41 -0400Associated Presscrop-biotech-company-expand-150-173241540Allergies are certainly the result of both genetic and environmental factors, but there is fresh evidence to suggest that at least one major genetic aberration could be behind everything from hay fever to food allergies to asthma.http://news.yahoo.com/single-genetic-glitch-may-explain-most-allergies-asthma-150047701.htmlThu, 25 Jul 2013 11:00:47 -0400Time.comsingle-genetic-glitch-may-explain-most-allergies-asthma-150047701(Reuters) - Thermo Fisher Scientific Inc reported a second-quarter profit that was slightly ahead of analysts' expectation, and said it was making progress in planning for its $13.6 billion acquisition of genetic testing company Life Technologies Inc . Thermo Fisher, the world's largest maker of laboratory equipment and scientific instruments, said its net profit rose to $277.4 million, or 76 cents per share, in the quarter ended June 29 from $233.8 million, or 63 cents per share, a year ago. Excluding special items, Thermo Fisher earned $1.32 per share. Analysts on average expected $1. ...http://news.yahoo.com/thermo-fisher-second-quarter-profit-narrowly-beats-estimates-100724726.htmlWed, 24 Jul 2013 06:07:24 -0400Reutersthermo-fisher-second-quarter-profit-narrowly-beats-estimates-100724726Illumina Inc., which makes genetic testing tools, said Tuesday that its net income climbed 53 percent in the second quarter as it booked fewer charges and posted a big jump in product and service revenue. ...http://news.yahoo.com/illumina-says-2q-net-income-230632889.htmlTue, 23 Jul 2013 19:06:32 -0400Associated Pressillumina-says-2q-net-income-230632889Two studies zero in on DNA-based drivers of weight. Is obesity written in our genes?http://news.yahoo.com/news-genes-idd-obesity-much-weight-genetic-094549684.htmlFri, 19 Jul 2013 05:45:49 -0400Time.comnews-genes-idd-obesity-much-weight-genetic-094549684By Deena Beasley (Reuters) - National Cancer Institute scientists have released the largest-ever database of cancer-related genetic variations, providing researchers the most comprehensive way so far to figure out how to target treatments for the disease. Open access worldwide to the new database, based on genome studies, is expected to help researchers accelerate development of new drugs and better match patients with therapies, NCI said in a statement on Monday. "Most anti-cancer drugs that are used today are used based on their empirical activity," Dr. ...http://news.yahoo.com/largest-cancer-gene-database-made-public-232153763.htmlMon, 15 Jul 2013 19:21:53 -0400Reuterslargest-cancer-gene-database-made-public-232153763<p><a href="http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.html"><img src="http://l.yimg.com/bt/api/res/1.2/jeVsgLvIwwPLuyxd8rMoOg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-15T184811Z_1_CBRE96E1G8E00_RTROPTP_2_BRITAIN.JPG" width="130" height="86" alt="A man sits on a bench in central London" align="left" title="A man sits on a bench in central London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem. A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why. ...</p><br clear="all"/>http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.htmlMon, 15 Jul 2013 14:49:20 -0400Reutersscientists-obesity-gene-makes-people-fat-160050035<p><a href="http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.html"><img src="http://l.yimg.com/bt/api/res/1.2/jeVsgLvIwwPLuyxd8rMoOg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-15T184811Z_1_CBRE96E1G8E00_RTROPTP_2_BRITAIN.JPG" width="130" height="86" alt="A man sits on a bench in central London" align="left" title="A man sits on a bench in central London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem. A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why. ...</p><br clear="all"/>By Esha Dey and Pallavi Ail (Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the Cambridge, Massachusetts-based company now is to prove that its 'gene silencing' technology can make the leap from the laboratory to the doctor's office and eclipse an alternative therapy already in use. Investors, for now, are betting that it will. A steady drip of positive trial data has helped to triple Alnylam's market value to more than $2. ...http://news.yahoo.com/alnylam-bets-gene-silencing-woo-biotech-investors-144723013.htmlFri, 12 Jul 2013 10:47:23 -0400Reutersalnylam-bets-gene-silencing-woo-biotech-investors-144723013(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein that causes a rare organ-damaging hereditary disorder. Alnylam shares rose 14 percent to $42.80 in premarket trade. The study was testing a subcutaneously administered version of the drug, ALN-TTR, to treat genetic disorder amyloidosis, which is caused by deposits of protein in tissues and organs. ...http://news.yahoo.com/alnylam-drug-found-effective-treating-rare-genetic-disease-132403151.htmlThu, 11 Jul 2013 09:24:03 -0400Reutersalnylam-drug-found-effective-treating-rare-genetic-disease-132403151Myriad Genetics Inc. is suing two privately-held competitors to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-overs-cancer-223108993.htmlWed, 10 Jul 2013 18:31:08 -0400Associated Pressmyriad-sues-competitor-overs-cancer-223108993Myriad Genetics Inc. is suing a privately-held competitor to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-over-cancer-205137780.htmlWed, 10 Jul 2013 16:51:37 -0400Associated Pressmyriad-sues-competitor-over-cancer-205137780<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/>http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.htmlTue, 09 Jul 2013 13:10:48 -0400Reutersfirst-child-receive-windpipe-grown-own-stem-cells-160616412<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/><p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.htmlWed, 03 Jul 2013 07:36:09 -0400Associated Press2-stem-cell-patients-stop-hiv-drugs-no-112746486<p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>By Kate Kelland LONDON (Reuters) - Scientists have for the first time created a functional human liver from stem cells derived from skin and blood and say their success points to a future where much-needed livers and other transplant organs could be made in a laboratory. While it may take another 10 years before lab-grown livers could be used to treat patients, the Japanese scientists say they now have important proof of concept that paves the way for more ambitious organ-growing experiments. ...http://news.yahoo.com/scientists-create-human-liver-stem-cells-033554646.htmlWed, 03 Jul 2013 23:35:54 -0400Reutersscientists-create-human-liver-stem-cells-033554646By Ben Hirschler LONDON (Reuters) - Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday. Both patients, who were treated in Boston and had been on long-term drug therapy to control their HIV, received stem-cell transplants after developing lymphoma, a type of blood cancer. ...http://news.yahoo.com/stem-cell-therapy-wipes-hiv-two-patients-115302059.htmlWed, 03 Jul 2013 07:53:02 -0400Reutersstem-cell-therapy-wipes-hiv-two-patients-115302059<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>http://news.yahoo.com/world-food-prize-goes-3-170632624.htmlWed, 19 Jun 2013 14:39:54 -0400Associated Pressworld-food-prize-goes-3-170632624<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>NEW YORK (AP) ? Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut.http://news.yahoo.com/bluebird-bio-shares-rocket-higher-trading-debut-152519370.htmlWed, 19 Jun 2013 19:12:45 -0400Associated Pressbluebird-bio-shares-rocket-higher-trading-debut-152519370<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.htmlThu, 13 Jun 2013 19:35:35 -0400Associated Presscourt-ruling-may-open-breast-cancer-gene-tests-180022078<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>By Sharon Begley NEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already moved on. ...http://news.yahoo.com/top-court-invalidates-gene-patents-biotech-moved-230732022.htmlThu, 13 Jun 2013 19:07:32 -0400Reuterstop-court-invalidates-gene-patents-biotech-moved-230732022ROLLERCOASTER REACTION: Diagnostic test maker Myriad Genetics saw its shares jump 10 percent, then plunge. The volatility was triggered by the Supreme Court's mixed ruling on the validity of patents for ...http://news.yahoo.com/news-summary-myriad-stock-volatile-224626640.htmlThu, 13 Jun 2013 18:46:26 -0400Associated Pressnews-summary-myriad-stock-volatile-224626640Shares of diagnostic test maker Myriad Genetics Inc. surged Thursday after the Supreme Court handed the company a partial victory in a battle over validity of Myriad patents underlying its lucrative test ...http://news.yahoo.com/high-court-ruling-gene-patents-155411757.htmlThu, 13 Jun 2013 15:08:11 -0400Associated Presshigh-court-ruling-gene-patents-155411757<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.htmlMon, 10 Jun 2013 17:12:14 -0400Reutersanalysis-biotech-wheat-furor-shows-gm-food-safety-210446592<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>

Source: http://rss.news.yahoo.com/rss/biotech

mexico news the talented mr ripley weather new orleans orcl the hartford illinois primary 2012 michael bay